This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Herijgers, N. Articles by Van Berkel, T. J. C. Search for Related Content PubMed PubMed Citation Articles by Herijgers, N. Articles by Van Berkel, T. J. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Bone Marrow Transplantation Hazardous Substances DB CHOLESTEROL

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1995-2003.)
© 1997 American Heart Association, Inc.

Articles

Effect of Bone Marrow Transplantation on Lipoprotein Metabolism and Atherosclerosis in LDL Receptor–Knockout Mice

Nicole Herijgers; Miranda Van Eck; Pieter H. E. Groot; Peter M. Hoogerbrugge; ; Theo J. C. Van Berkel

From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Sylvius Laboratories, Leiden University, Leiden, Netherlands (N.H., M. van E., Th.J.C. van B.); SmithKline Beecham Research and Development, Harlow, UK (P.H.E.G.); and the Department of Pediatrics, University Hospital, Leiden, Netherlands (P.M.H.).

Correspondence to Dr Nicole Herijgers, Division of Biopharmaceutics, Sylvius Laboratories, Leiden University, Wassenaarseweg 72, 2333 AL Leiden, the Netherlands. E-mail Herijgers{at}LACDR.LeidenUniv.nl

Abstract The LDL receptor (LDLR) plays an important role in the removal of LDL and its precursors, the intermediate and very low density lipoproteins, from the blood circulation. The receptor is expressed on various cell types. In this study the relative importance of the LDLR on macrophages for lipoprotein metabolism and atherogenesis was assessed. For this purpose, irradiated LDLR-knockout (-/-) mice were transplanted with bone marrow of normal C57BL/6J mice. DNA analysis showed that the transplanted mice were chimeric. The transplantation resulted in a slight decrease of total serum cholesterol when compared with LDLR-/- mice that were transplanted with LDLR-/- bone marrow. This modest decrease, however, did not reach statistical significance at all time points examined. This decrease can be almost completely attributed to a decrease in LDL cholesterol. The specific lowering of LDL cholesterol could clearly be observed at 4 weeks after transplantation, but the decrease was less at 12 weeks after transplantation. Quantification of atherosclerotic lesions of mice fed a 1% cholesterol diet for 6 months revealed that there were no differences in mean lesion area between mice transplanted with wild-type bone marrow or LDLR-/- bone marrow. We anticipate that in LDLR-/- mice transplanted with wild-type bone marrow, the LDLR is downregulated by the relatively high concentrations of circulating cholesterol. In vitro incubations of peritoneal macrophages with ¹²⁵I-LDL indicated that the LDLR of these cells could be downregulated by 25-hydroxycholesterol. Peritoneal macrophages isolated from LDLR-/- mice transplanted with wild-type bone marrow, in contrast to those transplanted with LDLR-/- bone marrow, were able to degrade ¹²⁵I-LDL, indicating that the capacity to express functional LDLR was achieved. In conclusion, introduction of the LDLR into LDLR -/- mice via bone marrow transplantation resulted in only a relatively modest decrease of LDL cholesterol that became less pronounced at later time points, possibly due to downregulation of the LDLR. To utilize the LDLR in macrophages for effective cholesterol lowering, either the sterol-regulatory elements have to be "silenced" or a high-expression LDLR construct has to be introduced into macrophages, eg, via transplantation of in vitro transfected hematopoietic stem cells.

Key Words: LDL receptor • atherosclerosis • lipoprotein metabolism • gene transfer • macrophages • Kupffer cells

This article has been cited by other articles:

				M. Altenburg, L. Johnson, J. Wilder, and N. Maeda Apolipoprotein E4 in Macrophages Enhances Atherogenesis in a Low Density Lipoprotein Receptor-dependent Manner J. Biol. Chem., March 16, 2007; 282(11): 7817 - 7824. [Abstract] [Full Text] [PDF]

				E. J.A. van Wanrooij, H. Happe, A. D. Hauer, P. de Vos, T. Imanishi, H. Fujiwara, T. J.C. van Berkel, and J. Kuiper HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2642 - 2647. [Abstract] [Full Text] [PDF]

				I. Bot, J. Guo, M. Van Eck, P. J. Van Santbrink, P. H. E. Groot, R. B. Hildebrand, J. Seppen, T. J. C. Van Berkel, and E. A. L. Biessen Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo Blood, August 15, 2005; 106(4): 1147 - 1153. [Abstract] [Full Text] [PDF]

				J. Liu, D. P. Thewke, Y. R. Su, M. F. Linton, S. Fazio, and M. S. Sinensky Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 174 - 179. [Abstract] [Full Text] [PDF]

				N. Levin, E. D. Bischoff, C. L. Daige, D. Thomas, C. T. Vu, R. A. Heyman, R. K. Tangirala, and I. G. Schulman Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 135 - 142. [Abstract] [Full Text] [PDF]

				S. D. Covey, M. Krieger, W. Wang, M. Penman, and B. L. Trigatti Scavenger Receptor Class B Type I-Mediated Protection Against Atherosclerosis in LDL Receptor-Negative Mice Involves Its Expression in Bone Marrow-Derived Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1589 - 1594. [Abstract] [Full Text] [PDF]

				J. Guo, M. Van Eck, J. Twisk, N. Maeda, G. M. Benson, P. H.E. Groot, and T. J.C. Van Berkel Transplantation of Monocyte CC-Chemokine Receptor 2-Deficient Bone Marrow Into ApoE3-Leiden Mice Inhibits Atherogenesis Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 447 - 453. [Abstract] [Full Text] [PDF]

				S. C. Whitman, D. L. Rateri, S. J. Szilvassy, J. A. Cornicelli, and A. Daugherty Macrophage-specific expression of class A scavenger receptors in LDL receptor-/- mice decreases atherosclerosis and changes spleen morphology J. Lipid Res., August 1, 2002; 43(8): 1201 - 1208. [Abstract] [Full Text] [PDF]

				V. V. Kunjathoor, D. S. Chiu, K. D. O'Brien, and R. C. LeBoeuf Accumulation of Biglycan and Perlecan, but Not Versican, in Lesions of Murine Models of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 462 - 468. [Abstract] [Full Text] [PDF]

				P. J. Tacken, B. Teusink, M. C. Jong, D. Harats, L. M. Havekes, K. W. van Dijk, and M. H. Hofker LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice J. Lipid Res., December 1, 2000; 41(12): 2055 - 2062. [Abstract] [Full Text]

				V. R. Babaev, L. A. Gleaves, K. J. Carter, H. Suzuki, T. Kodama, S. Fazio, and M. F. Linton Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2593 - 2599. [Abstract] [Full Text] [PDF]

				M. Van Eck, M. P. J. De Winther, N. Herijgers, L. M. Havekes, M. H. Hofker, P. H. E. Groot, and T. J. C. Van Berkel Effect of Human Scavenger Receptor Class A Overexpression in Bone Marrow-Derived Cells on Cholesterol Levels and Atherosclerosis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2600 - 2606. [Abstract] [Full Text] [PDF]

				N. Herijgers, M. P. J. de Winther, M. Van Eck, L. M. Havekes, M. H. Hofker, P. M. Hoogerbrugge, and T. J. C. Van Berkel Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice J. Lipid Res., September 1, 2000; 41(9): 1402 - 1409. [Abstract] [Full Text]

				N. Herijgers, M. Van Eck, P. H. E. Groot, P. M. Hoogerbrugge, and T. J. C. Van Berkel Low Density Lipoprotein Receptor of Macrophages Facilitates Atherosclerotic Lesion Formation in C57Bl/6 Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1961 - 1967. [Abstract] [Full Text] [PDF]

				N. Herijgers, M. Van Eck, S. J. A. Korporaal, P. M. Hoogerbrugge, and T. J. C. Van Berkel Relative importance of the LDL receptor and scavenger receptor class B in the {beta}-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages J. Lipid Res., July 1, 2000; 41(7): 1163 - 1171. [Abstract] [Full Text]

				M. Van Eck, N. Herijgers, K. W. Van Dijk, L. M. Havekes, M. H. Hofker, P. H. E. Groot, and T. J. C. Van Berkel Effect of Macrophage-Derived Mouse ApoE, Human ApoE3-Leiden, and Human ApoE2 (Arg158->Cys) on Cholesterol Levels and Atherosclerosis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 119 - 127. [Abstract] [Full Text] [PDF]

				M. F. Linton, V. R. Babaev, L. A. Gleaves, and S. Fazio A Direct Role for the Macrophage Low Density Lipoprotein Receptor in Atherosclerotic Lesion Formation J. Biol. Chem., July 2, 1999; 274(27): 19204 - 19210. [Abstract] [Full Text] [PDF]

				B. J.M. van Vlijmen, G. Gerritsen, A. L. Franken, L. S.M. Boesten, M. M. Kockx, M. J. Gijbels, M. P. Vierboom, M. van Eck, B. van de Water, T. J.C. van Berkel, et al. Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice Circ. Res., April 27, 2001; 88(8): 780 - 786. [Abstract] [Full Text] [PDF]